A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric Kit and Instructions for Use.

Authors:
Mills A; Myers L; Raudenbush C; Vossen DA; Teppler H and 4 more

Journal:
Pediatr Infect Dis J

Publication Year: 2022

DOI:
10.1097/INF.0000000000003334

PMCID:
PMC8658952

PMID:
34694252

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pediatr Infect Dis J

Abbreviation: Pediatr Infect Dis J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in…
Kujawski SA; Casey CS; Haas H and 4 more (2024) - Transparency Score: 3/6
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Chi…
Blanchard-Rohner G; Sanchez C; Andre MC and 11 more (2024) - Transparency Score: 3/6
Epidemiology and Clinical Characteristics of Human Metapneumovirus Infections in Hospitalized Child…
Steinberg R; Marty V; Korten I and 3 more (2024) - Transparency Score: 3/6
Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights F…
Di Chiara C; Boracchini R; Cantarutti A and 5 more (2024) - Transparency Score: 3/6
Trends in Otitis Media Ambulatory Visits in American Indian and Alaska Native Children During the P…
Bressler SS; Bruden D; Hammitt LL and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"A.M., C.R., D.A.V., H.T., Y.R.M., S.S., B.H. and W.L.S. worked on the ISENTRESS development team. All authors report being employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, and stockholders of Merck & Co., Inc., Kenilworth, NJ, USA."

Evidence found in paper:

"Writing assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025